We specialize in API delivery technologies and offer three distinct
Patent-Pending systems to give you the ability to design your products as pharmaceutical API delivery systems. All nanoQuick types are fully tunable, Patent-Pending, Self-Emulsifying Drug Delivery System (SEDDS) solutions that improve solubility, enhance micelle stability, increase absorption potential, and increase bioavailability of the API using food-grade ingredients and lab-tested processes. monarQh addresses the primary methods of API absorption in the body via three formulations:
nanoQuick S: Sublingual and Transdermal delivery
nanoQuick S is not an emulsion; it is a true water-soluble pharma-grade drug delivery system that does not utilize an oil formula, so it can be used as a sublingual or transdermal (with a carrier agent). NanoQuick S creates a stable nano-particle-sized water-soluble micellar colloidal suspension for cannabinoids and other water-insoluble APIs. This is a faster on-set and shorter duration delivery system
Finished format: APIs suspended in water
Bloodstream absorption potential: 90%+
Particle Size: 10-30 Nanometers
Best Applications: Beverages, some gummy formulations and edibles that rely on a water phase as part of the finished product.
nanoQuick L: Lymphatic delivery
nanoQuick L is a patent-pending system that addresses the entire Lymphatic Transport System (“LTS”) and utilizes carrier oils supporting the LTS as part of the system. NanoQuick L is designed to bypass the Hepatic Transport System , which also includes the first-pass liver metabolism stage, so the API isn’t subjected to enzyme API conversion.
This is a more sustained, longer-duration delivery system.
Finished format: APIs suspended in nanoQuick L carrier oils
Bloodstream absorption potential: 80%+
Micelle Size: 50-100 Nanometers
Best Applications: Edibles including Gummies, Beverages (when utilizing and external emulsification stage).
nanoQuick H: Hepatic delivery
nanoQuick H is a patent-pending system that addresses the entire Hepatic Transport System (“HTS”) and utilizes carrier oils supporting the HTS as part of the system. NanoQuick H is designed to support the HTS that also includes the first-pass liver metabolism stage so the API is subjected to enzyme API conversion. This is a faster on-set with additional API conversion effects and a shorter time duration delivery system.
Finished format: APIs suspended in nanoQuick H carrier oils
Bloodstream absorption potential: 70%+ ( original and converted API)
Micelle Size: 50-100 Nanometers
Best Applications: Edibles including Gummies, Beverages (when utilizing and external emulsification stage).